To celebrate its first two decades, COFEPRIS held an event to continue promoting innovation and health protection.

After COFEPRIS denied a transparency request for the approval document of the Sinovac vaccine, INAI urged the council to deliver the document.

COFEPRIS’s recent update is expected to spur innovation on drug therapies and encourage investment on innovation.

After many controversial reform proposals during AMLO’s administration, the sector sees a calmer future.

COFEPRIS has greenlit the single-dose vaccine. This may entail better vaccination rates and relief efforts

COVID-19 is not the only concern for the health industry. Learn about the potential threat nitrosamine poses to the pharma market.

Hospital pharmacies are receiving high-risk drugs in Dutch, Russian and Arabic, which no one can read. The risk to patients is massive.

Fair distribution and cooperation are essential to get over crisis. Are all countries contributing to the same cause?

Ethics is important in clinical research, and guidelines have been developed to provide clarity because many people are involved in a clinical trial.